SCYNEXIS Inc (SCYX) shareholders
Close on Nov 17, 2026Market cap $28.36MP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Squadron Master Fund LP Joint filing with Squadron Capital Management LLC (9.60%), Matthew Sesterhenn (9.60%) and 1 more | 7,608,695 | 9.60% | 13G (passive) | Mar 31, 2026 |
| Avidity Private Master Fund I LP Joint filing with Avidity Partners Management LP (9.90%), Avidity Partners Management (GP) LLC (9.90%) and 4 more | 4,516,757 | 9.90% | 13G (passive) amendment | Sep 30, 2025 |
| Michael Gregory Joint filing with Avidity Partners Management LP (9.90%), Avidity Partners Management (GP) LLC (9.90%) and 3 more | 4,426,565 | 9.90% | 13G (passive) amendment | Dec 31, 2025 |
| Avidity Master Fund LP Joint filing with Avidity Partners Management LP (9.90%), Avidity Partners Management (GP) LLC (9.90%) and 4 more | 4,211,870 | 9.90% | 13G (passive) amendment | Dec 31, 2024 |
| Great Point Partners, LLC Joint filing with Dr. Jeffrey R. Jay, M.D. (9.99%), Ms. Lillian Nordahl (9.99%) | 4,076,068 | 9.99% | 13G (passive) amendment | Jun 30, 2026 |
| CVI Investments, Inc. Joint filing with Heights Capital Management, Inc. (6.20%) | 3,956,319 | 6.20% | 13G (passive) amendment | Mar 31, 2026 |
| Voting Shares Irrevocable Trust Joint filing with Federated Hermes, Inc. (8.42%), Thomas R. Donahue (8.42%) and 2 more | 3,533,250 | 8.42% | 13G (passive) amendment | Dec 31, 2025 |
| Adage Capital Management, L.P. Joint filing with Robert Atchinson (9.99%), Phillip Gross (9.99%) | 1,041,824 | 9.99% | 13G (passive) | Jun 30, 2026 |
| Heights Capital Management, Inc. Joint filing with CVI Investments, Inc. (5.90%) | 615,522 | 5.90% | 13G (passive) amendment | Jun 30, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of SCYX | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Great Point Partners LLC | 944,292 | 9.49% | $3.84M | −1 | 0.73% |
| Squadron Capital Management LLC | 756,884 | 7.61% | $3.08M | −194,203 | 0.96% |
| Propel Bio Management, LLC | 543,478 | 5.46% | $2.21M | New | 1.16% |
| Adage Capital Partners Gp, L.L.C. | 543,478 | 5.46% | $2.21M | New | 0.00% |
| Woodline Partners LP | 387,520 | 3.89% | $1.58M | New | 0.00% |
| Vanguard Capital Management LLC | 296,747 | 2.98% | $1.21M | +101,197 | 0.00% |
| Avidity Partners Management LP | 260,206 | 2.62% | $1.06M | −260,210 | 0.17% |
| Kingdon Capital Management, L.L.C. | 247,811 | 2.49% | $1.01M | – | 0.10% |
| Millennium Management LLC | 180,788 | 1.82% | $735.81K | +103,018 | 0.00% |
| Heights Capital Management, Inc | 150,551 | 1.51% | $612.74K | −110,319 | 0.14% |
| DAFNA Capital Management LLC | 135,868 | 1.37% | $552.98K | −2 | 0.11% |
| Empery Asset Management, LP | 126,451 | 1.27% | $514.66K | −104,527 | 0.60% |
| Acadian Asset Management LLC | 116,669 | 1.17% | $473.00K | +25,175 | 0.00% |
| Geode Capital Management, LLC | 82,093 | 0.83% | $334.17K | +21,297 | 0.00% |
| Renaissance Technologies LLC | 76,525 | 0.77% | $311.46K | +48,445 | 0.00% |
| Vanguard Fiduciary Trust Co | 57,970 | 0.58% | $235.94K | +29,753 | 0.00% |
| ADAR1 Capital Management, LLC | 49,387 | 0.50% | $201.01K | New | 0.01% |
| BlackRock, Inc. | 41,522 | 0.42% | $169.00K | −2 | 0.00% |
| Velan Capital Investment Management LP | 40,000 | 0.40% | $162.80K | New | 0.10% |
| Northern Trust Corp | 22,385 | 0.22% | $91.11K | +10,438 | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 39 | 5M | 51.7% | 11 / 12 | 12 / 15 | 2M | 1M |
| Q1 2026 | 44 | 4M | 40.1% | 14 / 9 | 11 / 6 | 3M | 0M |
| Q4 2025 | 37 | 1M | 10.9% | 6 / 10 | 7 / 10 | 0M | 1M |
| Q3 2025 | 42 | 1M | 14.8% | 7 / 7 | 11 / 4 | 0M | 0M |
| Q2 2025 | 39 | 1M | 14.0% | 6 / 10 | 7 / 6 | 0M | 0M |
| Q1 2025 | 40 | 1M | 14.6% | 4 / 7 | 13 / 12 | 0M | 0M |
| Q4 2024 | 48 | 2M | 15.2% | 11 / 16 | 7 / 4 | 0M | 0M |
| Q3 2024 | 43 | 2M | 16.5% | 4 / 12 | 11 / 13 | 0M | 0M |
| Q2 2024 | 53 | 2M | 17.4% | 8 / 11 | 18 / 9 | 0M | 0M |
| Q1 2024 | 54 | 2M | 18.7% | 9 / 11 | 20 / 7 | 0M | 1M |
| Q4 2023 | 53 | 2M | 23.6% | 8 / 22 | 10 / 13 | 1M | 0M |
| Q3 2023 | 60 | 2M | 20.8% | 16 / 12 | 14 / 8 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
8 funds held SCYX in Q2 2026, 84% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of SCYX | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 152,542 | 1.53% | $620.85K | 0.00% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 128,195 | 1.29% | $521.75K | 0.00% | Jun 30, 2026 |
| EA Bridgeway Omni Small-Cap Value ETF | 15,462 | 0.16% | $62.93K | 0.00% | Jun 30, 2026 |
| Vanguard Balanced Index Fund | 5,910 | 0.06% | $24.05K | 0.00% | Jun 30, 2026 |
| Dimensional U.S. Small Cap ETF | 5,189 | 0.05% | $25.11K | 0.00% | Jul 31, 2026 |
| U.S. Micro Cap Portfolio | 4,831 | 0.05% | $23.38K | 0.00% | Jul 31, 2026 |
| U.S. Vector Equity Portfolio | 2,278 | 0.02% | $11.03K | 0.00% | Jul 31, 2026 |
| Victory Extended Market Index Fund | 1,099 | 0.01% | $5.32K | 0.00% | Jul 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Gonzalez David Angulo | Chief Executive Officer, Director | 1,357,126 | 13.64% | Apr 2, 2026 |
| Sanjay Subramanian | Chief Financial Officer | – | – | Sep 11, 2026 |
| ivor Macleod | Chief Financial Officer | 398,529 | 4.01% | Feb 2, 2026 |
| Scott Sukenick | Chief Legal Officer | 574,539 | 5.77% | Feb 2, 2026 |
| Steven Keith Burke | Director | 5,750 | 0.06% | Sep 22, 2026 |
| Guy Macdonald | Director | 12,625 | 0.13% | Jun 30, 2026 |
| Armando Anido | Director | 11,750 | 0.12% | Jun 30, 2026 |
| Ann Hanham | Director | 11,577 | 0.12% | Jun 30, 2026 |
| Brian Philippe Tinmouth | Director | 12,125 | 0.12% | Jun 30, 2026 |
| David C. Hastings | Director | 11,522 | 0.12% | Jun 30, 2026 |
| Steven C. Gilman | Director | 70,000 | 0.70% | Jun 30, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Steven Keith Burke Director | Sep 18, 2026 | Award | +5,750 | – | – | 5,750 |
| Brian Philippe Tinmouth Director | Jun 26, 2026 | Award | +2,875 | – | – | 12,125 |
| Ann Hanham Director | Jun 26, 2026 | Award | +2,875 | – | – | 11,577 |
| Armando Anido Director | Jun 26, 2026 | Award | +2,875 | – | – | 11,750 |
| Guy Macdonald Director | Jun 26, 2026 | Award | +2,875 | – | – | 12,625 |
| David C. Hastings Director | Jun 26, 2026 | Award | +2,875 | – | – | 11,522 |
| Gonzalez David Angulo Chief Executive Officer, Director | Apr 1, 2026 | Buy | +108,695 | – | – | 1,357,126 |
| Gonzalez David Angulo Chief Executive Officer, Director | Jan 29, 2026 | Award | +391,333 | – | – | 1,244,431 |
| Scott Sukenick Chief Legal Officer | Jan 29, 2026 | Award | +129,833 | – | – | 574,539 |
| ivor Macleod Chief Financial Officer | Jan 29, 2026 | Award | +129,833 | – | – | 398,529 |
| Gonzalez David Angulo Chief Executive Officer, Director | Oct 17, 2025 | Award | +32,500 | $0.76 | $24.70K | 853,098 |
| Brian Philippe Tinmouth Director | Jun 26, 2025 | Award | +23,000 | – | – | 74,000 |
| Armando Anido Director | Jun 26, 2025 | Award | +23,000 | – | – | 71,000 |
| Steven C. Gilman Director | Jun 26, 2025 | Award | +23,000 | – | – | 70,000 |
| Ann Hanham Director | Jun 26, 2025 | Award | +23,000 | – | – | 69,622 |
| David C. Hastings Director | Jun 26, 2025 | Award | +23,000 | – | – | 69,183 |
| Guy Macdonald Director | Jun 26, 2025 | Award | +23,000 | – | – | 78,000 |
| Gonzalez David Angulo Chief Executive Officer, Director | Apr 9, 2025 | Award | +23,000 | $0.84 | $19.32K | 816,598 |
| Gonzalez David Angulo Chief Executive Officer, Director | Mar 20, 2025 | Award | +13,800 | $1.05 | $14.49K | 793,598 |
| Gonzalez David Angulo Chief Executive Officer, Director | Mar 19, 2025 | Award | +5,000 | $1.07 | $5.35K | 779,798 |
| ivor Macleod Chief Financial Officer | Jan 23, 2025 | Award | +92,511 | – | – | 260,696 |
| Gonzalez David Angulo Chief Executive Officer, Director | Jan 23, 2025 | Award | +262,927 | – | – | 770,798 |
| Scott Sukenick Chief Legal Officer | Jan 23, 2025 | Award | +92,511 | – | – | 436,706 |
| Gonzalez David Angulo Chief Executive Officer, Director | Sep 12, 2024 | Buy | +20,000 | $1.37 | $27.40K | 507,871 |
| Brian Philippe Tinmouth Director | Jun 20, 2024 | Award | +23,000 | – | – | 51,000 |
| Armando Anido Director | Jun 20, 2024 | Award | +23,000 | – | – | 48,000 |
| Steven C. Gilman Director | Jun 20, 2024 | Award | +23,000 | – | – | 47,000 |
| Guy Macdonald Director | Jun 20, 2024 | Award | +23,000 | – | – | 55,000 |
| Ann Hanham Director | Jun 20, 2024 | Award | +23,000 | – | – | 46,622 |
| David C. Hastings Director | Jun 20, 2024 | Award | +23,000 | – | – | 46,183 |
| Scott Sukenick Chief Legal Officer | Feb 16, 2024 | Tax withholding | −15,179 | $1.63 | $24.74K | 336,195 |
| Scott Sukenick Chief Legal Officer | Jan 26, 2024 | Award | +143,675 | – | – | 351,374 |
| Gonzalez David Angulo Chief Executive Officer, Director | Jan 26, 2024 | Award | +290,590 | – | – | 479,871 |
| ivor Macleod Chief Financial Officer | Jan 26, 2024 | Award | +143,675 | – | – | 160,185 |
| Ann Hanham Director | Jun 15, 2023 | Award | +10,000 | – | – | 23,622 |
| David C. Hastings Director | Jun 15, 2023 | Award | +10,000 | – | – | 23,183 |
| Steven C. Gilman Director | Jun 15, 2023 | Award | +10,000 | – | – | 24,000 |
| Brian Philippe Tinmouth Director | Jun 15, 2023 | Award | +10,000 | – | – | 28,000 |
| Guy Macdonald Director | Jun 15, 2023 | Award | +10,000 | – | – | 32,000 |
| Armando Anido Director | Jun 15, 2023 | Award | +10,000 | – | – | 25,000 |
| Scott Sukenick Chief Legal Officer | May 15, 2023 | Award | +50,000 | – | – | 203,599 |
| Scott Sukenick General Counsel | Jan 27, 2023 | Award | +100,000 | – | – | 153,599 |
| Gonzalez David Angulo Chief Executive Officer | Jan 1, 2023 | Award | +110,000 | – | – | 185,181 |
| ivor Macleod Chief Financial Officer | Oct 24, 2022 | Award | +15,000 | – | – | 15,000 |
| David C. Hastings Director | Jun 17, 2022 | Award | +10,000 | – | – | 13,183 |
| Guy Macdonald Director | Jun 17, 2022 | Award | +10,000 | – | – | 22,000 |
| Armando Anido Director | Jun 17, 2022 | Award | +10,000 | – | – | 15,000 |
| Brian Philippe Tinmouth Director | Jun 17, 2022 | Award | +10,000 | – | – | 18,000 |
| Steven C. Gilman Director | Jun 17, 2022 | Award | +10,000 | – | – | 14,000 |
| Ann Hanham Director | Jun 17, 2022 | Award | +10,000 | – | – | 13,622 |
| Marco Taglietti Chief Executive Officer, Director | Apr 26, 2022 | Buy | +75,000 | $3.00 | $225.00K | 272,068 |
| Scott Sukenick General Counsel | Apr 26, 2022 | Buy | +3,500 | $3.00 | $10.50K | 53,499 |
| Gonzalez David Angulo Chief Medical Officer | Feb 4, 2022 | Award | +51,100 | – | – | 74,981 |
| Scott Sukenick General Counsel | Feb 4, 2022 | Award | +40,700 | – | – | 49,899 |
| Christine Coyne Chief Commercial Officer | Feb 4, 2022 | Award | +43,200 | – | – | 58,200 |
| Marco Taglietti Chief Executive Officer, Director | Feb 4, 2022 | Award | +87,200 | – | – | 196,968 |
| Christine Coyne Chief Commercial Officer | May 10, 2021 | Award | +15,000 | – | – | 15,000 |
| Life Sciences Master Fund Ltd Perceptive 10% owner | Jan 22, 2021 | Sale | −285,151 | $8.16 | $2.33M | 1,833,849 |
| Life Sciences Master Fund Ltd Perceptive 10% owner | Jan 22, 2021 | Sale | −33,849 | $8.95 | $302.95K | 1,800,000 |
| Life Sciences Master Fund Ltd Perceptive 10% owner | Jan 21, 2021 | Sale | −95,000 | $7.38 | $701.10K | 2,120,000 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Scynexis's stock actually held short. Settlement fails (shares not delivered on time) peaked at 51,927 shares on Sep 29, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Federated Hermes Kaufmann Fund II, a portfolio of Federated Hermes Insurance Series 10% Stockholder | Dec 18, 2024 | 9,418 | $11.58K | Dec 18, 2024 | Secondary Offering - Open Market |
| Federated Hermes Kaufmann Fund, a portfolio of Federated Hermes Equity Funds 10% Stockholder | Dec 18, 2024 | 332,668 | $409.18K | Dec 18, 2024 | Secondary Offering - Open Market |
| Federated Hermes Kaufmann Small Cap Fund, a portfolio of Federated Hermes Equity Funds 10% Stockholder | Dec 18, 2024 | 257,914 | $317.23K | Dec 18, 2024 | Secondary Offering - Open Market |
| Federated Hermes Kaufmann Fund, a portfolio of Federated Hermes Equity Funds 10% Stockholder | Dec 11, 2024 | 388,113 | $477.38K | Dec 11, 2024 | Secondary Offering-Open Market |
| Federated Hermes Kaufmann Fund II, a portfolio of Federated Hermes Insurance Series 10% Stockholder | Dec 11, 2024 | 10,988 | $13.52K | Dec 11, 2024 | Secondary Offering-Open Market |
| Federated Hermes Kaufmann Small Cap Fund, a portfolio of Federated Hermes Equity FUnds 10% Stockholder | Dec 11, 2024 | 300,899 | $370.11K | Dec 11, 2024 | Secondary Offering - Open Market |
| Federated Hermes Kaufmann Fund II, a portfolio of Federated Hermes Insurance Series 10% Stockholder | Aug 27, 2024 | 9,700 | $17.17K | Aug 22, 2024 | Secondary Offering /Open Market |
| Federated Hermes Kaufmann Small Cap Fund, a portfolio of Federated Hermes Equity Funds 10% Stockholder | Aug 27, 2024 | 272,000 | $481.44K | Aug 22, 2024 | Secondary Offering /Open Market |
| Federated Hermes Kaufmann Fund, a portfolio of Federated Hermes Equity Funds 10% Stockholder | Aug 27, 2024 | 338,000 | $598.26K | Aug 22, 2024 | Secondary Offering /Open Market |
| Federated Hermes Kaufmann Fund, a portfolio of Federated Hermes Equity Funds 10% Stockholder | Aug 22, 2024 | 338,000 | $598.26K | Aug 22, 2024 | Secondary Offering / Open Market |
| Federated Hermes Kaufmann Small Cap Fund, a portfolio of Federated Hermes Equity Funds 10% Stockholder | Aug 22, 2024 | 272,000 | $481.44K | Aug 22, 2024 | Secondary Offering / Open Market |
| Federated Hermes Kaufmann Fund II, a portfolio of Federated Hermes Insurance Series 10% Stockholder | Aug 22, 2024 | 9,700 | $17.17K | Aug 22, 2024 | Secondary Offering / Open Market |
| Federated Hermes Kaufmann Small Cap Fund, a portfolio of Federated Hermes Equity Funds 10% Stockholder | Feb 9, 2024 | 477,101 | $1.02M | Feb 9, 2024 | Secondary Offering / Open Market |
| Federated Hermes Kaufmann Small Cap Fund, a portfolio of Federated Hermes Equity Funds 10% Stockholder | Feb 5, 2024 | 590,000 | $1.26M | Feb 5, 2024 | Secondary Offering / Open Market |
| Federated Hermes Kaufmann Fund II, a portfolio of Federated Hermes Insurance Series 10% Stock | Sep 22, 2023 | 9,214 | $31.54K | Sep 21, 2023 | Secondary Offering / Open Market |
See a number that looks wrong?